Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients

BACKGROUND: Highly efficacious vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed. However, the emergence of viral variants that are more infectious than the earlier SARS-CoV-2 strains is concerning. Several of these viral variants have the potential to...

Descripción completa

Detalles Bibliográficos
Autores principales: Carreño, Juan Manuel, Alshammary, Hala, Singh, Gagandeep, Raskin, Ariel, Amanat, Fatima, Amoako, Angela, Gonzalez-Reiche, Ana Silvia, van de Guchte, Adriana, study group, PARIS, Srivastava, Komal, Sordillo, Emilia Mia, Sather, D. Noah, van Bakel, Harm, Krammer, Florian, Simon, Viviana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527879/
https://www.ncbi.nlm.nih.gov/pubmed/34688034
http://dx.doi.org/10.1016/j.ebiom.2021.103626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527879/
https://www.ncbi.nlm.nih.gov/pubmed/34688034
http://dx.doi.org/10.1016/j.ebiom.2021.103626

Ejemplares similares